Connect. Grow. Succeed. Your Project Is Our Focus

摘要

Rentschler Biotechnologie GmbH is a global, full-service contract manufacturer with over 35 years of experience in the development, production, and approval of biopharmaceuticals in compliance with international GMP standards (EMA/FDA). As part of theRentschler Group and headquartered in Laupheim, Germany, Rentschler is one of three leading European CMOs operating globally. Dedicated to delivering high-quality biopharmaceuticals produced in mammalian cell culture, Rentschler has nine stand-alone GMPsuites with volumes of 30 L, 250 L, 500 L, 1,000 L, and 2,500 L, which allows producing material for clinical trials and supplying the market. As a pioneer in the development and production of biopharmaceuticals, Rentschler was the first company in theworld to gain market authorization for an interferon-containing drug. The company is an independent, family-owned business and currently has about 650 employees.